Emergency authorization of Regeneron Pharmaceuticals’ Covid-19 antibody drug now includes an injectable version, which is a more convenient option for patients. The drug developer plans to seek full FDA approval of its antibody cocktail later this summer.
In addition to 11 recipients of the inaugural Changemaker in Health Awards, George Halvorson will receive the first HIMSS Changemaker Lifetime Achievement Award.
MedCity News
Read about new developments from Stellar Health, Paige, venBio, and more.
Shares0
Stellar Health is pleased to announce the appointment of JoRel Nye, former Senior Vice President of Technical Product Management at Aledade as its new Chief Product Officer.
Stellar Health is a point-of-care, cloud-based platform that helps primary care providers continually engage with their patients by providing them real-time information and tangible action-based incentives for improving quality of care. Stellar Health’s mission is to enable all providers to engage and succeed in VBC by bridging the incentive gap between providers and payors. To read more,
Paige co-founder Dr. David Klimstra has been named Chief Medical Officer, a role that will start in August. Klimstra is currently Chair of the Department of Pathology at Memorial Sloan Kettering Cancer Center. In his new role, Klimstra will lead the clinical implementation and evidence generation for Paige’s technology and
Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.
HHS is partnering with nonprofit Global Health Investment Corporation to launch a health security fund. The fund will be used to invest in technologies that can help prevent or respond to public health emergencies, like future pandemics.